
2025 International Symposium on Poison Control and Research Development
November 14–16, 2025 | Taipei Veterans General Hospital, Taiwan
Venue: Chih-Teh Building, Taipei Veterans General Hospital. (1F, No. 322, Sec. 2, Shipai Rd., Beitou District, Taipei City, Taiwan)
The 2025 International Symposium on Poison Control and Research Development brings together global experts in clinical toxicology, emergency medicine, and CBRNe preparedness to share the latest advances in poison control, research innovation, and medical response strategies.
Over three days, the symposium will feature keynote lectures, workshops, and practical training programs co-hosted with MedGlobal, covering topics from chemical and radiological disaster response to novel antidote development and AI-assisted mass casualty triage.
Registration is now open!
We look forward to welcoming you to Taipei for three days of insightful exchange and collaboration.
Day 1 — Clinical Toxicology Approach to CBRNe
Nov, 14 08:00-17:30
The opening day of the 2025 International Symposium on Poison Control and Research Development focuses on bridging clinical toxicology with CBRNe preparedness and response. Experts from the United States, Estonia, France, and Taiwan will share their experiences in managing chemical and radiological disasters, developing novel therapeutics, and applying artificial intelligence to mass casualty triage.
The program includes four sessions covering CBRNE readiness, clinical skills, natural toxins, and emerging treatment strategies—highlighting the interdisciplinary collaboration between poison centers and emergency medical networks worldwide.
Featured speakers include Dr. Alvin C. Bronstein (America’s Poison Centers, USA), Dr. Luke Yip (Denver Health, USA), Dr. Raido Paasma (West-Tallinn Central Hospital, Estonia), Dr. Farshad Mazda Shirazi (Arizona Poison and Drug Information Center, USA), Dr. Kim D. Janda (Scripps Research, USA), and Dr. Bruno Mégarbane (Paris University, France), along with senior experts from Taiwan’s poison and clinical toxicology community.
Agenda
Time |
Topic / Speaker |
Duration |
---|---|---|
08:00–08:15 |
Registration |
|
08:15–08:25 |
Opening Remarks |
10 min |
|
Session 1 – CBRNE Readiness & Hazard Management Session Moderators Dr. Chen-Chang Yang (Taipei Veterans General Hospital, Taiwan) Dr. Wen-Chi Fann (Chang Gung Memorial Hospital, Chiayi, Taiwan) |
|
08:25–09:00 |
CBRN Disaster Response: Lessons from Two Rail Car Events Dr. Alvin C. Bronstein (America's Poison Centers, USA) |
35 min |
09:00–09:25 |
CBRN”E” Overview Dr. Luke Yip (Denver Health, Rocky Mountain Poison & Drug Safety, USA) |
25 min |
09:25–09:50 |
Chemical HAZMAT incidents – How to Manage and Be Prepared |
25min |
CWA in Baltic Sea – Possible Chemical Threat or Sleeping Disaster |
||
09:50–10:05 |
Tea Break |
15 min |
|
Session 2 – Clinical Skills & Emerging Tools Session Moderators |
|
10:05–10:20 |
Structured Trauma Ultrasound (EFAST): Theory and Practical Training Dr. Chia-Chin Chen (Chang Bing Show-Chwan Memorial Hospital, Changhua) |
15 min |
10:20–10:50 |
Training for Rare Nuclear, Biological, or Chemical Events: How to Optimize Learning and Skills? |
30 min |
10:50–11:20 |
Ionizing Radiation Exposure and Injury: Improving Competency for Clinicians |
30 min |
11:20–11:50 |
Artificial Intelligence-Enhanced Mass Casualty Triage in Poison Centers: Revolutionizing Emergency Response to Chemical Disasters |
30 min |
11:50–12:00 |
Panel Discussion & Q&A |
10 min |
12:00–13:30 |
Lunch Break |
90 min |
|
Session 3 – Natural Toxins Session Moderators |
|
13:30–14:15 |
Bongkrekic Acid Poisoning Outbreak in Taiwan Dr. Jou-Fang Deng (Taipei Veterans General Hospital, Taiwan) |
45 min |
14:15–15:00 |
Natural Toxins as Warfare Agents and Countermeasures (Virtual) |
45 min |
15:00–15:30 |
Palytoxin |
30 min |
15:30–15:45 |
Tea Break |
15 min |
|
Session 4 – Novel Therapeutics Session Moderators Dr. Luke Yip (Denver Health, Rocky Mountain Poison & Drug Safety, USA) |
|
15:45–16:25 |
Small Molecule Inhibitors for the Treatment of Botulinum Intoxication Dr. Kim D. Janda (Scripps Research, USA) |
40 min |
16:25–17:05 |
Synthetic Opioid and Adulterant Toxicity: Antibodies/Vaccines as a Treatment Platform for Toxicity Reversal Dr. Kim D. Janda (Scripps Research, USA) |
40 min |
17:05–17:30 |
Panel Discussion & Q&A |
25 min |